Dr. Nicolas Gaudenzio
Chief Scientific Officer, Genoskin
Dr Gaudenzio holds a doctorate in immunology and completed his PhD in 2012 at the University of Toulouse, France. Following his post-doctorate in the Department of Pathology at Stanford University (CA, USA), he now heads a large Inserm cross-disciplinary research group, which was awarded a Starting Grant from the European Research Council (ERC) in 2018. His work has contributed substantially to identifying molecular and cellular targets involved in allergic and non-allergic inflammation and developing new data analysis processes to study preclinical models and clinical samples from patients. In 2021, Dr Gaudenzio received the prestigious ACTERIA Early Career Research Prize in Allergology and the award of physiology and medicine from the French Academy of Sciences in Lyon, France.